Genetic testing for lung adenocarcinoma
Part of Cancer clinical trials.
This study looks at inherited genetic changes in people with a type of lung cancer called lung adenocarcinoma. The goal is to find gene variants linked to the disease, which may help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 16 years old.
- You must have been diagnosed with lung adenocarcinoma (a type of lung cancer).
- You must have a life expectancy of at least 8 weeks.
- You must have had a blood sample taken that is available for testing.
- You must have complete medical records available to the researchers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for biological markers (biomarkers) in your cancer tissue to help predict whether the tumor might spread through air spaces. It aims to better understand your cancer and may help guide future treatment decisions.
This study looks at how certain gene variations (called ADH1B and ALDH) may affect the risk of developing lung cancer. By comparing people with lung cancer to healthy individuals, researchers hope to learn more about who might be at higher risk.
This study tests a shared decision-making approach to help people with lung adenocarcinoma decide whether to get molecular (genetic) testing. It aims to improve understanding and support better choices about testing and possible targeted treatments.
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
This study looks for inherited (family-passed) genetic changes that may raise the risk of lung cancer and related thoracic cancers. It may help people and families understand their genetic risk by collecting health information and sometimes specimens from patients and relatives.
This study collects and analyzes lung cancer tissue samples to understand genetic differences that may help guide future treatment. You'll provide a tissue sample (either from a biopsy or prior surgery), and researchers will study it—no treatment is given in this study.
Hear when a new Lung Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.